You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Johnson & Johnson JNJ is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing ...

Wall Street reacted generally positively to the 15% tariff rate cap on pharmaceutical exports from the EU, sending shares of ...

Wall Street reacted generally positively to the 15% tariff rate cap on pharmaceutical exports from the EU, sending shares of ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

FutureWise Research today announces the upcoming release of its comprehensive report, Alzheimer’s Disease Diagnostic Market – ...

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

Healthcare technology company Philips announced that it is investing more than $150 million in U.S. manufacturing and ...

Rigel's Q2 results highlight soaring revenue and raised guidance for 2025. See more on RIGL stock's growth potential, ...